Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100042904Phase 4Recruiting
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Department of Anesthesiology, Zhangjiajie People's Hospital. Primary endpoint: Success rate of sedation. Started Aug 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100042904.